Andrew J. Dosch

Andrew J. Dosch

Auto-generated profile, based on publicly available information

Andrew J. Dosch

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
CCChase M. Carver
Chase M. Carver
SRSonia L. Rodriguez
Sonia L. Rodriguez
EAElizabeth J. Atkinson
Elizabeth J. Atkinson
ADAndrew J. Dosch
Andrew J. Dosch
NANiels C. Asmussen
Niels C. Asmussen
MSMarissa J. Schafer
Marissa J. Schafer
Cellular senescence is an aging mechanism characterized by cell cycle arrest and a senescence-associated secretory phenotype (SASP). Preclinical studies demonstrate that senolytic drugs, which target survival pathways in senescent cells, can counteract age-associated conditions that span several organs. The comparative efficacy of distinct senolytic drugs for modifying aging and senescence biomarkers in vivo has not been demonstrated. Here, we established aging- and senescence-related plasma proteins and tissue transcripts that changed in old versus young female and male mice. We investigated responsivity to acute treatment with venetoclax, navitoclax, fisetin or luteolin versus transgenic senescent cell clearance in aged p16-InkAttac mice. We discovered that age-dependent changes in plasma proteins, including IL-23R, CCL5 and CA13, were reversed by senotherapeutics, which corresponded to expression differences in tissues, particularly in the kidney. In plasma from humans across the lifespan, IL-23R increased with age. Our results reveal circulating factors as candidate mediators of senescence-associated interorgan signal transduction and translationally impactful biomarkers of systemic senescent cell burden.

6 October 2022 in Frontiers in Aging
Verified
Journal Article
Open access
SRSonia L. Rodriguez
Sonia L. Rodriguez
CCChase M. Carver
Chase M. Carver
ADAndrew J. Dosch
Andrew J. Dosch
DHDerek M. Huffman
Derek M. Huffman
FBFelicia D. Duke Boynton
Felicia D. Duke Boynton
MSMarissa J. Schafer
Marissa J. Schafer
Surgical parabiosis enables sharing of the circulating milieu between two organisms. This powerful model presents diverse complications based on age, strain, sex, and other experimental parameters. Here, we provide an optimized parabiosis protocol for the surgical union of two mice internally at the elbow and knee joints with continuous external joining of the skin. This protocol incorporates guidance and solutions to complications that can occur, particularly in aging studies, including non-cohesive pairing, variable anesthesia sensitivity, external and internal dehiscence, dehydration, and weight loss. We also offer a straightforward method for validating postoperative blood chimerism and confirming its time course using flow cytometry. Utilization of our optimized protocol can facilitate reproducible parabiosis experimentation to dynamically explore mechanisms of aging and rejuvenation.